Signaling Pathway
Nadecnemab is an IgG4?? monoclonal antibody that targets GDNF family receptor alpha 3 (GFRA3), a receptor involved in neurotrophic signaling. Nadecnemab is suitable for research into chronic pain and osteoarthritis of the knee, particularly in models examining the GDNF?€?RET signaling axis.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Nadecnemab is an IgG4?? monoclonal antibody that targets GDNF family receptor alpha 3 (GFRA3), a receptor involved in neurotrophic signaling. Nadecnemab is suitable for research into chronic pain and osteoarthritis of the knee, particularly in models examining the GDNF?€?RET signaling axis. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
